☆ 4.7 Letter

Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients

ANNALS OF THE RHEUMATIC DISEASES (2012)

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 71, Issue 12, Pages 2061-U186

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2011-200389

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Rheumatology

Predictors of progression to systemic sclerosis: analysis of very early diagnosis of systemic sclerosis in a large single-centre cohort

Valdirene S. Siqueira, Mariely F. S. Helbingen, Ana Cristina Medeiros-Ribeiro, Henrique Carrico da Silva, Renata Miossi, Ana Paula Luppino-Assad, Percival D. Sampaio-Barros

Summary: This study analyzed the early characteristics of SSc in RP patients and identified predictors for the progression to SSc. Combinations of RP + PF + positive ANA + SD-NFC and/or SSc-specific antibody (VEDOSS level 2), as well as RP + PF + positive ANA (VEDOSS level 1; "red flags") were most associated with progression to SSc. Combinations without non-RP clinical symptoms, such as RP + SD-NFC and RP + anticentromere + SD-NFC, were associated with non-progression to SSc.

RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience

Maria Vlachou, Hossam Fayed, Adele Dawson, Sally Reddecliffe, Alexander Stevenson, Ross J. Thomson, Benjamin Emmanuel Schreiber, J. Gerry Coghlan

Summary: The study evaluated survival rates and short-term impact of i.v. prostanoids on SSc-PAH patients. Significant improvements in clinical and haemodynamic parameters were observed with i.v. prostanoid therapy. However, survival remains poor and risk scoring at baseline and during therapy can improve prognostication.

RHEUMATOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience

Eva Revilla-Lopez, Cristina Berastegui, Alejandra Mendez, Berta Saez-Gimenez, Victoria Ruiz de Miguel, Manuel Lopez-Meseguer, Victor Monforte, Carlos Bravo, Miguel Angel Pujana, Maria Antonia Ramon, Susana Gomez-Olles, Antonio Roman

Summary: This study found that sirolimus treatment had a positive long-term effect on most LAM patients, with 59% showing a positive response, 30% showing a partial response, and 11% showing a negative response after 5 years of treatment.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Oncology

Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer

Beatriz E. Adrada, Rosalind Candelaria, Stacy Moulder, Alastair Thompson, Peng Wei, Gary J. Whitman, Vicente Valero, Jennifer K. Litton, Lumarie Santiago, Marion E. Scoggins, Tanya W. Moseley, Jason B. White, Elizabeth E. Ravenberg, Wei T. Yang, Gaiane M. Rauch

Summary: The study evaluated the performance of early ultrasound evaluation after two cycles of neoadjuvant systemic therapy in identifying excellent responders among patients with triple-negative breast cancer. Results suggested that the tumor volume reduction percentage by ultrasound after two cycles could serve as a cost-effective imaging biomarker for predicting a pathologic complete response to therapy.

CANCER (2021)

Add to Collection

Article Medicine, General & Internal

Prevalence of anti-synthetase antibodies among systemic sclerosis patients

Wakar Garra, Yair Levy

Summary: This study aimed to estimate the prevalence of Anti-ARS antibodies among patients with systemic sclerosis and evaluate their clinical associations and risk factors for interstitial lung disease. The results showed a 6% prevalence of Anti-ARS antibodies, which were associated with the development of ILD.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Article Rheumatology

Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea

J. W. Ha, J. Y. Pyo, S. S. Ahn, J. J. Song, Y-B Park, S-W Lee

Summary: The study found no significant associations between ANCA positivity and the cross-sectional clinical features or all-cause mortality during follow-up in Korean SSc patients. However, three female patients with ANCA were later diagnosed with microscopic polyangiitis during follow-up, suggesting the importance of considering biopsy in SSc patients with suspected AAV.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis

Alyxzandria M. Gaydosik, Tracy Tabib, Robyn Domsic, Dinesh Khanna, Robert Lafyatis, Patrizia Fuschiotti

Summary: Through single-cell transcriptome analysis, different subsets of T cells in healthy and SSc skin were identified, each associated with distinct signaling pathways. A unique subset of recirculating CXCL13(+) T cells in SSc skin was discovered, expressing a T helper follicular-like gene expression signature and potentially promoting B-cell responses in the inflamed skin of patients.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study

Amra Adrovic, Mehmet Yildiz, Fatih Haslak, Oya Koker, Ayten Aliyeva, Sezgin Sahin, Kenan Barut, Ozgur Kasapcopur

Summary: The study evaluated the efficacy of TCZ treatment in JSS patients, showing significant improvements in HRCT, PGA, and DLCO, as well as reductions in mRSS and J4S scores. TCZ may be a potential treatment option for patients who do not respond to conventional therapy.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Article Immunology

Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage

Chiara Bellocchi, Xuan Wang, Marka A. Lyons, Maurizio Marchini, Maurizio Lorini, Vincenzo Carbonelli, Nicola Montano, Shervin Assassi, Lorenzo Beretta

Summary: This study aimed to characterize differential expressed pathways in subjects with preclinical systemic sclerosis (PreSSc). The study found significant differences in Reactome pathways between PreSSc and healthy controls (HC). Progression of PreSSc was associated with changes in signal transduction pathways, particularly those related to calcium and inositol 1,4,5-triphosphate metabolism.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Clinical Neurology

Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study

Federico Montini, Agostino Nozzolillo, Paola M. V. Rancoita, Chiara Zanetta, Lucia Moiola, Federica Cugnata, Federica Esposito, Maria A. Rocca, Vittorio Martinelli, Massimo Filippi

Summary: This study assessed modifiable risk factors associated with COVID-19 in people with multiple sclerosis (PwMS). The results showed that higher vitamin D levels and active smoking status were associated with a lower risk of COVID-19, while external contact and working in the healthcare sector increased the risk. Therefore, vitamin D supplementation and teleworking may help prevent infection risk in PwMS.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Rheumatology

Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database

Michele Iudici, Matthias Jarlborg, Kim Lauper, Ulf Mueller-Ladner, Vanessa Smith, Yannick Allanore, Alexandra Balbir-Gurman, Andrea Doria, Paolo Airo, Ulrich A. Walker, Valeria Riccieri, Madelon C. Vonk, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Gabriella Szucs, Thierry Martin, Oliver Distler, Delphine S. Courvoisier

Summary: The objective of this study was to assess the extent of ineligibility and determine the reasons for it in SSc patients included in the EUSTAR database. The study found that the representativeness of patients in SSc-RCTs varies greatly, and is more influenced by treatment and safety factors rather than demographic criteria.

RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Angiotensin-converting enzyme 1 gene polymorphisms in patients with systemic sclerosis-associated interstitial lung disease: a single centre retrospective observational study

Boris Karanovic, Marko Baresic, Ana Merkler Sorgic, Branimir Anic

Summary: This retrospective study analyzed the association between ACE 1 gene polymorphisms and SSc-ILD in terms of disease features, pulmonary function tests, and lung HRCT changes over different time periods. The results showed no significant differences in the development and severity of SSc-ILD and changes in pulmonary function tests between different ACE 1 gene polymorphism subgroups. However, patients with the ID genotype showed a significant reduction in FEV1 after 10 years of follow-up.

RHEUMATOLOGY INTERNATIONAL (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Ross procedure in adult patients: a single-centre analysis of long-term results up to 28 years

Claudia Oeser, Keziban Uyanik-Uenal, Alfred Kocher, Guenther Laufer, Martin Andreas

Summary: This study provides an in-depth insight into the outcomes of the Ross procedure, showing that patients operated on by high-volume surgeons have lower odds of serious adverse events compared to those operated on by low-volume surgeons. It also suggests that supporting the autograft can reduce the risk of reintervention in patients with preoperative aortic regurgitation.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Add to Collection

Article Nutrition & Dietetics

Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients

Monica Verdoia, Matteo Nardin, Roberta Rolla, Federica Negro, Rocco Gioscia, Arraa Maddalena Saghir Afifeh, Filippo Viglione, Harry Suryapranata, Marco Marcolongo, Giuseppe De Luca

Summary: The study revealed that among patients with cardiovascular disease, vitamin D deficiency is associated with a higher metabolic and clinical risk profile, as well as elevated inflammatory parameters, predicting higher levels of inflammatory indicators in the body.

CLINICAL NUTRITION (2021)

Add to Collection

Article Medicine, General & Internal

Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population

Anna B. Marcinkowska, Sergiusz Jozwiak, Agnieszka Tarasewicz, Alicja Debska-Slizien, Edyta Szurowska

Summary: This study aimed to describe the neuropsychiatric profile of adults with Tuberous Sclerosis Complex (TSC) and found that TSC-associated neuropsychiatric disorders (TANDs) are common in adults with TSC and are often underdiagnosed. It revealed that most individuals with TSC present multiple behavioral and cognitive problems. Patients with intellectual disability and epilepsy had more neuropsychiatric problems than those without epilepsy. The study emphasizes the importance of wide dissemination and application of TAND screening for early identification, prevention, and rehabilitation of difficulties in TSC patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Respiratory System

Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry

Marius M. Hoeper, Christine Pausch, Ekkehard Gruenig, Gerd Staehler, Doerte Huscher, David Pittrow, Karen M. Olsson, Carmine Dario Vizza, Henning Gall, Oliver Distler, Christian Opitz, J. Simon R. Gibbs, Marion Delcroix, H. Ardeschir Ghofrani, Stephan Rosenkranz, Da-Hee Park, Ralf Ewert, Harald Kaemmerer, Tobias J. Lange, Hans-Joachim Kabitz, Dirk Skowasch, Andris Skride, Martin Claussen, Juergen Behr, Katrin Milger, Michael Halank, Heinrike Wilkens, Hans-Juergen Seyfarth, Matthias Held, Daniel Dumitrescu, Iraklis Tsangaris, Anton Vonk-Noordegraaf, Silvia Ulrich, Hans Klose

Summary: In recent years, the use of combination therapy has increased in patients with pulmonary arterial hypertension, but most patients still receive monotherapy. There was no change in the one-year survival rate over time, but there was a slight, nonsignificant improvement in the three-year survival rate.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Respiratory System

COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

Marius M. Hoeper, Christine Pausch, Karen M. Olsson, Doerte Huscher, David Pittrow, Ekkehard Gruenig, Gerd Staehler, Carmine Dario Vizza, Henning Gall, Oliver Distler, Christian Opitz, J. Simon R. Gibbs, Marion Delcroix, H. Ardeschir Ghofrani, Da-Hee Park, Ralf Ewert, Harald Kaemmerer, Hans-Joachim Kabitz, Dirk Skowasch, Juergen Behr, Katrin Milger, Michael Halank, Heinrike Wilkens, Hans-Juergen Seyfarth, Matthias Held, Daniel Dumitrescu, Iraklis Tsangaris, Anton Vonk-Noordegraaf, Silvia Ulrich, Hans Klose, Martin Claussen, Tobias J. Lange, Stephan Rosenkranz

Summary: The study investigated a modified risk stratification approach based on four risk categories, using refined cutoff levels for functional class, 6MWD, and BNP/NT-proBNP. The four-stratum model was found to be more sensitive in predicting long-term survival and prognostic changes compared to the original three-stratum model.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Clinical Neurology

Aneurysmal subarachnoid hemorrhage in Germany between 2005 and 2018: A nationwide observational study

Christian Uhl, Doerthe Huscher, Jenny Sommerfeld, Benn Schoenberg, Peter Vajkoczy, Nora F. Dengler

Summary: In Germany, the incidence of aSAH decreased between 2005 and 2018, especially in younger age groups. This may reflect effects of lifestyle adjustments most pronounced in younger age groups.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Critical Care Medicine

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

Marius M. Hoeper, Krit Dwivedi, Christine Pausch, Robert A. Lewis, Karen M. Olsson, Doerte Huscher, David Pittrow, Ekkehard Gruenig, Gerd Staehler, Carmine Dario Vizza, Henning Gall, Oliver Distler, Christian Opitz, John Simon R. Gibbs, Marion Delcroix, Da-Hee Park, Hossein Ardeschir Ghofrani, Ralf Ewert, Harald Kaemmerer, Hans-Joachim Kabitz, Dirk Skowasch, Juergen Behr, Katrin Milger, Tobias J. Lange, Heinrike Wilkens, Hans-Juergen Seyfarth, Matthias Held, Daniel Dumitrescu, Iraklis Tsangaris, Anton Vonk-Noordegraaf, Silvia Ulrich, Hans Klose, Martin Claussen, Stephan Eisenmann, Kai-Helge Schmidt, Andrew J. Swift, Alfred A. Roger Thompson, Charlie A. Elliot, Stephan Rosenkranz, Robin Condliffe, David G. Kiely, Michael Halank

Summary: This study provides a detailed characterization of patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH) and identifies a distinct lung phenotype characterized by low diffusion capacity for carbon monoxide (DLCO) and smoking history. These patients resemble those with pulmonary hypertension due to lung disease rather than classical IPAH. These findings have important implications for understanding the pathogenesis, diagnosis, and treatment of the disease and warrant further exploration.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

Stephan Rosenkranz, Christine Pausch, John G. Coghlan, Doerte Huscher, David Pittrow, Ekkehard Gruenig, Gerd Staehler, Carmine Dario Vizza, Henning Gall, Oliver Distler, Marion Delcroix, Hossain A. Ghofrani, Ralf Ewert, Han -Joachim Kabitz, Dirk Skowasch, Juergen Behr, Katrin Milger, Michael Halank, Heinrike Wilkens, Hans-Juergen Seyfarth, Matthias Held, Laura Scelsi, Claus Neurohr, Anton Vonk-Noordegraaf, Silvia Ulrich, Hans Klose, Martin Claussen, Stephan Eisenmann, Kai-Helge Schmidt, Bjoern Andrew Remppis, Andris Skride, Elena Jureviciene, Lina Gumbiene, Skaidrius Miliauskas, Judith Loeffler-Ragg, Tobias J. Lange, Karen M. Olsson, Marius M. Hoeper, Christian Opitz

Summary: This study analyzed the response to PAH therapy in IPAH patients and compared the differences between patients without comorbidities, those with 1-2 comorbidities, and those with 3-4 comorbidities. The results showed that patients with comorbidities had smaller improvements in functional class, 6-minute walking distance, BNP/NT-pro-BNP, and mortality risk compared to patients without comorbidities. However, the 4-strata risk tool predicted the outcome in IPAH patients regardless of the presence of comorbidities.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Add to Collection

Article Multidisciplinary Sciences

The Abdominal Pain Unit (APU). Study protocol of a standardized and structured care pathway for patients with atraumatic abdominal pain in the emergency department: A stepped wedged cluster randomized controlled trial

Maria B. Altendorf, Martin Moeckel, Liane Schenk, Antje Fischer-Rosinsky, Johann Frick, Lukas Helbig, Dirk Horenkamp-Sonntag, Doerte Huscher, Luisa Lichtenberg, Thomas Reinhold, Daniel Schindel, Britta Stier, Hanna Sydow, Yves-Noel Wu, Grit Zimmermann, Anna Slagman

Summary: This study aims to improve emergency department care for patients with atraumatic abdominal pain by implementing an application-supported pathway. The study will use a mixed-methods multicentre cluster randomized controlled stepped wedge trial design and gather both quantitative and qualitative data.

PLOS ONE (2022)

Add to Collection

Article Rheumatology

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Alain Lescoat, Doerte Huscher, Nils Schoof, Paolo Airo, Jeska De Vries-Bouwstra, Gabriela Riemekasten, Eric Hachulla, Andrea Doria, Edoardo Rosato, Nicolas Hunzelmann, Carlomaurizio Montecucco, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler, Jennifer Ben Shimol, Maurizio Cutolo, Yannick Allanore

Summary: The prevalence and characteristics of SSc-associated interstitial lung disease (SSc-ILD) vary between geographical regions. This study aimed to explore the differences in prevalence, phenotype, treatment, and prognosis in patients with SSc-ILD from different regions in the EUSTAR database. The results showed significant variations in clinical characteristics, survival rates, and treatment approaches among different regions.

RHEUMATOLOGY (2023)

Add to Collection

Article Immunology

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis

Jakob Hoeppner, Christoph Tabeling, Vincent Casteleyn, Claudia Kedor, Wolfram Windisch, Gerd Ruediger Burmester, Doerte Huscher, Elise Siegert

Summary: The aim of this study was to comprehensively analyze the serum autoantibody status in patients with systemic sclerosis (SSc) and correlate it with the clinical course of the disease. The study found that specific autoantibodies are associated with specific clinical manifestations, while the association of some rare antibodies is not fully clarified. The results of this study reveal important associations between the serologic status of SSc patients and disease manifestation, comorbidities, and complications.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Geriatrics & Gerontology

Association of kidney function and albuminuria with frailty worsening and death in very old adults

Nina Mielke, Alice Schneider, Muhammad Helmi Barghouth, Natalie Ebert, Markus van der Giet, Doerte Huscher, Martin K. Kuhlmann, Elke Schaeffner

Summary: This study investigates the association between kidney function decline and albuminuria with frailty worsening or death in very old adults. The findings suggest that both advanced stages of CKD and albuminuria are independently associated with an increased risk of frailty worsening and death in older adults.

AGE AND AGEING (2023)

Add to Collection

Letter Respiratory System

Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis

Kai-Helge Schmidt, Katrin Milger, Christine Pausch, Doerte Huscher, David Pittrow, Ekkehard Gruenig, Gerd Staehler, Henning Gall, Oliver Distler, Dirk Skowasch, Michael Halank, Heinrike Wilkens, Matthias Held, Hans Klose, Marius M. Hoeper

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Article Immunology

Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study

Michael Borte, Leif G. G. Hanitsch, Nizar Mahlaoui, Maria Fasshauer, Dorte Huscher, Matthaios Speletas, Maria Dimou, Marta Kamieniak, Corinna Hermann, David Pittrow, Cinzia Milito

Summary: The FIGARO study aims to provide insights on the real-world utilization and tolerability of fSCIG for PID and SID patients. This prospective, multicenter study analyzed medical records, charts, and diaries of patients receiving fSCIG treatment for at least 1 year. The results showed that fSCIG is a feasible, well-tolerated treatment option with good infection control for both PID and SID patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Kidney Measures and Risk of Incident Heart Failure Among Older Adults

Antonios Douros, Alice Schneider, Natalie Ebert, Anne-Katrin Fietz, Dorte Huscher, Martin K. Kuhlmann, Peter Martus, Nina Mielke, Markus van der Giet, Volker Wenning, Elke Schaeffner

JACC-HEART FAILURE (2023)

Add to Collection

Article Oncology

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis

Maria Dimou, Matthaios Speletas, Cinzia Milito, Aleksandra Pyzik, Doerte Huscher, Marta Kamieniak, David Pittrow, Michael Borte

Summary: The study aimed to evaluate the clinical use and tolerability of facilitated subcutaneous immunoglobulin (fSCIG) in patients with secondary immunodeficiency (SID). The results demonstrated that fSCIG had a positive impact on the treatment experience of SID patients, with good efficacy and tolerability.

CANCERS (2023)

Add to Collection

Article Rheumatology

Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis

Tazio Maleitzke, Edgar Wiebe, Doerte Huscher, Cornelia M. M. Spies, Jinwen Tu, Timo Gaber, Yu Zheng, Frank Buttgereit, Markus J. J. Seibel, Hong Zhou

Summary: The role of endogenous glucocorticoid (GC) signaling in chronic inflammatory arthritis is not fully understood. This study investigated the impact of endogenous GC signaling in osteoblasts on inflammation and bone integrity using a long-term arthritis model.

ARTHRITIS RESEARCH & THERAPY (2023)

Add to Collection

Article Clinical Neurology

Diagnosis and treatment of meralgia paresthetica between 2005 and 2018: a national cohort study

Benn Schoenberg, Mareen Pigorsch, Doerte Huscher, Shlomo Baruchi, Jennifer Reinsch, Anna Zdunczyk, Christoph Scholz, Ann-Kathrin Uerschels, Nora F. Dengler

Summary: The prevalence of meralgia paresthetica (MP) caused by compression of the lateral femoral cutaneous nerve (LFCN) has been increasing in Germany. This study examines the diagnostic and therapeutic strategies as well as time trends in clinical MP management from 2005 to 2018. The study found an increase in imaging and non-imaging diagnostic studies, as well as a decrease in surgical procedures for MP.

NEUROSURGICAL REVIEW (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.